Larvol Delta - IND-approval-from-the-US-FDA-for-Phase-II-SARBombesin-imaging-trial-in-prostate-cancer

Cu-67 SAR-Bombesin - Clarity Pharma

https://www.prnewswire.com/news-releases/ind-approval-from-the-us-fda-for-phase-ii-sar-bombesin-imaging-trial-in-prostate-cancer-301561643.html

Jun 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next